Press release from Business Wire
SeeThruEquity Announces Company Lineup for Fall 2012 Smallcap and Microcap Investor Conference on October 2 and 3, 2012
<p> <b>Conference Will be Held at the Cornell Club in New York City</b> </p>
Monday, September 24, 2012
SeeThruEquity Announces Company Lineup for Fall 2012 Smallcap and Microcap Investor Conference on October 2 and 3, 201211:47 EDT Monday, September 24, 2012
NEW YORK (Business Wire) -- SeeThruEquity, a leading investment research and corporate access firm
focused on public smallcap and microcap companies, is hosting its Fall
Smallcap and Microcap Investor Conference on October 2 and 3, 2012 at
the Cornell Club in midtown Manhattan. Registration will begin at 7:45AM
on October 2 and will run from 8am to 5pm on October 2 and 12pm to 5pm
on October 3.
Senior management from a select group of companies will make
presentations about their respective businesses to an elite group of
institutional and retail investors, equity analysts and industry
professionals. 1-on-1 meetings between qualified investors and the
presenting companies will also be arranged by appointment.
Presenting companies to include:
Applied DNA Sciences Inc.
OTCBB: APDN
Bovie Medical Corp
NYSE: BVX
China Digital TV Holding Co
NYSE: STV
diaDexus, Inc
OTC: DDXS
International Stem Cell Corp
OTC: ISCO
Inuvo, Inc.
NYSE: INUV
Mac-Gray Corp
NYSE: TUC
Perma-Fix Environmental Services Inc.
NASDAQ: PESI
Quadrant 4 Systems Corp
OTC: QFOR
SoundBite Communications, Inc.
NASDAQ: SDBT
The Cash Store Financial Services, Inc.
NYSE: CSFS
Qualified investors and equity research analysts may attend the
conference without charge and other interested parties may join the
conference for a $149 fee. Please visit SeeThruEquity
Fall Conference Home Page for more information about the conference.
You may register for the conference by clicking SeeThruEquity
Fall Conference Attendee Registration.
About SeeThruEquity, LLC
SeeThruEquity, LLC is an investment research and corporate access firm
that produces high quality research reports on smallcap and microcap
companies with less than $1 billion in market capitalization. The
traditional Wall Street analyst establishment has typically underserved
these companies. We are unfettered by any ties to investment banking or
trading, and distribute our high impact research as an approved firm for
consensus estimates on Thomson Reuters, CapitalIQ, FactSet, Zacks and
StockTwits, as well as to our own audience of investors from our
corporate website.
Our philosophy is focused on delivering an unbiased,
institutional quality research product for such uncovered or
undercovered companies to all levels of investors in the investment
community and at absolutely no charge to the reader of the research or
the company being covered. We seek to build relationships between
corporate issuers and institutional and sophisticated investors via
compelling investor conferences and forums as well as non-deal road
shows.
SeeThruEquity, LLCJennifer Wolf, 646-495-0939info@seethruequity.com
